Back to results
US 2003/0171380 A1Published application
Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligands
AssigneeBristol-Myers Squibb Pharma Company
InventorsArgyrios G. Arvanitis, Paul J. Gilligan, Richard A. Hartz
Life of this patent
Estimating the term…
Abstract
Compounds provided herein are novel substituted pyrazinones, pyridines and pyrimidines of Formula (I) and (II): 1 Such compounds are particularly useful as CRF receptor ligands, and hence, in the treatment of various neurologically-related disorders such as affective disorder, anxiety and depression.
Claims24
A compound of Formula (I) or (II):
- 113
- or a pharmaceutically acceptable salt form thereof, wherein:
- X is N or CR1;
- provided that when X is N, R1 can not be either —NR9R10 or —NR9COR9;
- W is ═O, ═S, —H or (—H, —H);
- Y is —C(═O)—, —C(RY)2—, —C(RY)2CH2—, —OCH2—, —SOnCH2—, —N═, —NRY—, —O—, or —CH═;
- RY is independently, at each occurrence, selected from H, methyl, ethyl, and C1-C2 haloalkyl;
- B is R3, NHR3, NR3R1, OR3, or SOnR3;
- R1 is independently, at each occurrence, selected from H, halogen, —CN, C1-C4 haloalkyl, —NR9R10, —NR9COR9, —COR10, —OR10, SH, —S(°)nR12, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C3-C6 cycloalkyl, and C4-C8 cycloalkylalkyl;
- wherein each C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C3-C6 cycloalkyl, or C4-C8 cycloalkylalkyl is each optionally substituted with halogen, CN, C1-C4 haloalkyl, —NR9R10, —NR9COR9, —COR10, —OR10, SH or —S(O)nR12;
- R2 is H, halogen, CN, C1-C4 haloalkyl, —NR9R10, NR9COR9, —COR10, —OR10, SH, —S(O)nR12, C1-C4 alkyl, C3-C6 cycloalkyl, or C4-C8 cycloalkylalkyl;
- wherein each C1-C4 alkyl, C3-C6 cycloalkyl, or C4-C8 cycloalkylalkyl is optionally substituted with halogen, —CN, C1-C4 haloalkyl, —NR9R10, —NR9COR9, —COR10, —OR10, SH or —S(O)nR12;
- R2a is H, F, Cl, Br, —CN, —OH, methyl, ethyl, propyl, cyclopropyl, cyclobutyl, methoxy, ethoxy, propoxy, C1-C3 alkoxy, cyclopropyloxy-, —OCF3, —CF3, —CO2CH3, —CO2CH2CH3, —C(O)CH3, —C(O)CH2CH3, —CH2OH, —CH2OCH3, —CH2OCH2CH3, —C(O)NH2, —C(O)N(H)CH3, —C(O)N (H)CH2CH3, —C(O)N(CH3)2, —C(O)N(CH3)CH2CH3, —C(O)N(CH2CH3)2, —S(O)2N(CH3)2, —S(O)2N(CH3)CH2CH3, —S(O)2N(CH2CH3)2, —S(O)2CH3, —S(O)2CH2CH3, —NH2, —N(H)CH3, —N(H)CH2CH3, —N(CH3)2, —N(CH3)CH2CH3, —N(CH2CH3)2, or —N(H)CF3;
- R3 is C1-C10 alkyl, C3-C10 alkenyl, C3-C10 alkynyl, C3-C8 cycloalkyl, C4-C12 cycloalkylalkyl, C2-C10 alkoxyalkyl, C5-C10 cycloalkenyl, or C6-C10 cycloalkenylalkyl;
- wherein one carbon in any cycloalkyl ring may be replaced with O, S or NR9;
- and
- wherein each C1-C10 alkyl, C3-C10 alkenyl, C3-C8 alkynyl, C3-C8 cycloalkyl, C4-C12 cycloalkylalkyl, C2-C10 alkoxyalkyl, C5-C10 cycloalkenyl, or C6-C10 cycloalkenylalkyl is optionally substituted with 1, 2 or 3 substituents independently selected at each occurrence from C1-C6 alkyl, C2-C6 alkenyl, C2-C10 alkynyl, C3-C6 cycloalkyl, halogen, C1-C4 haloalkyl, cyano, —OR7, SH, —S(O)nR11, —COR6, —NHR6SO2R8, —OC(O)NR6R7, —N3, —OC(O)OR7, —CO2R8, —OC(O)R6, —NR7COR6, —N(COR6)2, —NR7CONR6R7, —NR7CO2R8, —NR6R7, —CONR6R7, —CO2H, aryl, heteroaryl and heterocyclyl;
- alternatively, R3 is —OR3a, —NR3aR3b, NHR3a, —SOnR3a, —SO2NHR3a, —SO2NR3aR3b, —COR3a, —CONHR3a, or —CONR3aR3b;
- R3a and R3b are independently selected from C1-C10 alkyl, C2-C10 alkenyl, C2-C10 alkynyl, C3-C8 cycloalkyl, C4-C12 cycloalkylalkyl, C2-C10 alkoxyalkyl, C5-C10 cycloalkenyl, and C6-C10 cycloalkenylalkyl;
- wherein one carbon in any cycloalkyl may be replaced with O, S or NR9;
- and
- wherein each C1-C10 alkyl, C2-C10 alkenyl, C2-C10 alkynyl, C3-C8 cycloalkyl, C4-C12 cycloalkylalkyl, C2-C10 alkoxyalkyl, C5-C10 cycloalkenyl, and C6-C10 cycloalkenylalkyl is optionally substituted with 1 to 3 substituents independently selected at each occurrence from C1-C6 alkyl, C2-C6 alkenyl, C2-C10 alkynyl, C3-C6 cycloalkyl, halogen, C1-C4 haloalkyl, cyano, —OR7, —SH, —S(O)nR11, —COR6, —CO2R8, —OC(O)R6, —NR7COR6, —N(COR6)2, —NR7CONR6R7, —NR7CO2R8, —NR6R7, —NHR6SO2R8, —OC(O)NR6R7, —N3, —OC(O) OR7, —CONR6R7, —CO2H, aryl, heteroaryl and heterocyclyl;
- R4 is independently selected in each occurrence from —H, —OR10, —COR9, —CO2R8, —CONR9R10, —CN, —NR9R10, —S(O)nR12, —S(O)2NR9R10, —NO2, halogen, C1-C6 alkyl, C1-C4 haloalkyl, C1-C6 haloalkoxy, C3-C6 cycloalkyl, C2-C6 alkenyl, C2-C6 alkynyl, aryl and heteroaryl;
- wherein C1-C6 alkyl, C1-C4 haloalkyl, C3-C6 cycloalkyl, C2-C6 alkenyl, and C2-C6 alkynyl, are optionally substituted with —OR10, —COR9, —CO2R8, —CONR9R10, —CN, —NR9R10, —S(O)nR12, or halogen;
- A1 is CR5 or N;
- A2 is CR5 or N;
- R5 is independently selected at each occurrence from —H, C1-C10 alkyl, C1-C4 haloalkyl, C1-C4 haloalkoxy, C2-C10 alkenyl, C2-C10 alkynyl, C3-C6 cycloalkyl, C4-C12 cycloalkylalkyl, —NO2, halogen, —CN, —NR6R7, —NR6COR7, —NR6CO2R8, —COR6—OR7, —CONR6R7, —CO(NOR9)R11, —CO2R8, —S(O)2NR9R10, and —S(O)nR11;
- wherein C1-C10 alkyl, C2-C10 alkenyl, C2-C10 alkynyl, C3-C6 cycloalkyl and C4-C12 cycloalkylalkyl are optionally substituted with 1 to 3 substituents independently selected at each occurrence from C1-C4 alkyl, C2-C4 alkenyl, C2-C4 alkynyl, C3-C6 cycloalkyl, C4-C8 cycloalkylalkyl, C1-C4 haloalkyl, —NO2, halogen, —CN, —NR6R7, —NR6COR7, NR6CO2R8, —COR6—OR7, —CONR6R7, —CO2R8, —CO(NOR9)R7, and —S(O)nR11;
- alternatively, two R5 groups on adjacent atoms can form a 5-7 membered fused ring, partially saturated or unsaturated, optionally containing 1-2 —O— or —SOn— or 1-3 N heteroatoms provided the ring does not contain any S—S, O—O, S—O or N—S bonds;
- said 5-7 membered fused ring optionally substituted with C1-C4 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C3-C6 cycloalkyl, C4-C8 cycloalkylalkyl, C1-C4 haloalkyl, —NO2, halogen, —CN, —NR6R7, NR6COR7, NR6CO2R8, —COR6—OR7, —CONR6R7, —CO2R8, —CO(NOR9)R7, or —S(O)nR11;
- R6 and R7 are independently at each occurrence H, C1-C6 alkyl, C1-C4 haloalkyl, C2-C8 alkoxyalkyl, C3-C6 cycloalkyl, C4-C12 cycloalkylalkyl, C5-C12 bis(alkoxy)alkyl, aryl, aryl(C1-C4 alkyl)-, heteroaryl or heteroaryl(C1-C4 alkyl);
- alternatively NR6R7 is piperidine, pyrrolidine, piperazine, N-methylpiperazine, morpholine or thiomorpholine;
- R8 is independently at each occurrence C1-C4 alkyl, C1-C4 haloalkyl, C3-C6 cycloalkyl, C4-C12 cycloalkylalkyl, aryl, aryl(C1-C4 alkyl)-, heteroaryl or heteroaryl(C1-C4 alkyl);
- R9 and R10 are independently at each occurrence selected from H, C1-C4 alkyl, C1-C4 haloalkyl, C3-C6 alkenyl, C3-C6 alkynyl, C3-C6 cycloalkyl, C2-C6 alkoxyalkyl, and C4-C7 cycloalkylalkyl;
- R11 is independently at each occurrence C1-C4 alkyl, C1-C4 haloalkyl, C3-C6 cycloalkyl, C4-C12 cycloalkylalkyl, aryl, aryl(C1-C4 alkyl)-, heteroaryl, heteroaryl(C1-C4 alkyl), or —NR6R7;
- R12 is independently at each occurrence C1-C4 alkyl, C1-C4 haloalkyl, C3-C6 alkenyl, C3-C6 alkynyl, C3-C6 cycloalkyl, or C4-C7 cycloalkylalkyl;
- aryl is phenyl or naphthyl, each optionally substituted with 1 to 5 substituents independently selected at each occurrence from C1-C6 alkyl, C3-C6 cycloalkyl, C4-C7 cycloalkylalkyl, C2-C6 alkenyl, C2-C6 alkynyl, halogen, C1-C4 haloalkyl, cyano, —OR30, —SH, —S(O)nR32, —COR32, —CO2R28, —OC(O)R32, —NR29COR29, —N(COR32)2, —NR29CONR29R30, —NR29CO2R28, —NR29R30, and —CONR29R30;
- heteroaryl is pyridyl, pyrimidinyl, pyrazinyl, pyridazinyl, triazinyl, furanyl, quinolinyl, isoquinolinyl, thienyl, imidazolyl, thiazolyl, indolyl, pyrrolyl, oxazolyl, benzofuranyl, benzothienyl, benzthiazolyl, isoxazolyl, pyrazolyl, triazolyl, tetrazolyl, or indazolyl, each optionally substituted with 1 to 3 substituents independently selected at each occurrence from C1-C6 alkyl, C3-C6 cycloalkyl, C4-C7 cycloalkylalkyl, C2-C6 alkenyl, C2-C6 alkynyl, halogen, C1-C4 haloalkyl, cyano, —OR30, —SH, —S(O)nR32, —COR32, —CO2R28, —OC(O)R32, —NR29COR29, —N(COR32)2, —NR29CONR29R30, —NR29CO2R28, —NR29R30, and —CONR29R30;
- heterocyclyl is saturated or partially saturated heteroaryl, optionally substituted with 1 to 3 substituents independently selected at each occurrence from C1-C6 alkyl, C3-C6 cycloalkyl, C4-C7 cycloalkylalkyl, C2-C6 alkenyl, C2-C6 alkynyl, halogen, C1-C4 haloalkyl, cyano, —OR30, SH, —S(O)nR32 -COR32, —CO2R32, —OC(O)R32, —NR29COR29, —N(COR32)2, —NR29CONR29R30, —NR29CO2R32, —NR29R30, and —CONR29R30;
- R28 is independently at each occurrence C1-C4 alkyl, C1-C4 haloalkyl, C3-C6 cycloalkyl, C4-C12 cycloalkylalkyl, phenyl, or phenyl(C1-C4 alkyl)-;
- R29 and R30 are independently at each occurrence selected from H, C1-C4 alkyl, C1-C4 haloalkyl, C3-C6 alkenyl, C3-C6 alkynyl, C3-C6 cycloalkyl, C2-C6 alkoxyalkyl, and C4-C7 cycloalkylalkyl;
- R32 is independently at each occurrence C1-C4 alkyl, C1-C4 haloalkyl, C3-C6 alkenyl, C3-C6 alkynyl, C3-C6 cycloalkyl, or C4-C7 cycloalkylalkyl;
- and n is 0, 1, or 2.
40 more elements
Dependencies are inferred from the claim text.